6 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Terminated 6 |
Follow Relapsing Remitting Multiple Sclerosis: new trials by email Literature Review of Relapsing Remitting Multiple Sclerosis trials Research Report on Relapsing Remitting Multiple Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fingolimod Versus Dimethyl-fumarate in Multiple Sclerosis Fingolimod, Dimethyl Fumarate - Relapsing Remitting Multiple Sclerosis | Phase 4 | Terminated | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 55 | 2017-04-30 | 2019-10-31 |
| Pilot Study to Assess Dimethyl Fumarate Related GI Symptom Mitigation Simethicone, Loperamide, Peanut Butter - Relapsing Remitting Multiple Sclerosis | Phase 4 | Terminated | Rocky Mountain MS Research Group, LLC | 5 | 2014-07-01 | 2017-03-23 |
| Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis Fingolimod - Relapsing Remitting Multiple Sclerosis | Phase 4 | Terminated | Heinrich-Heine University, Duesseldorf | 8 | 2013-01-01 | 2016-06-09 |
| How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose Interferon beta-1a - Relapsing Remitting Multiple Sclerosis | Phase 4 | Terminated | Biogen | 19 | 2007-06-01 | 2008-09-04 |
| Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate Glatiramer Acetate, Placebo, Prednisone - Relapsing Remitting Multiple Sclerosis | Phase 4 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 414 | 2005-01-01 | 2014-01-06 |
| Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS Glatiramer Acetate, Betaseron, Rebif - Relapsing Remitting Multiple Sclerosis | Phase 4 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 91 | 2004-07-01 | 2010-10-18 |
Multiple Sclerosis, Relapsing-Remitting (6) · Multiple Sclerosis (3)
Autoimmune Diseases (6) · Autoimmune Diseases of the Nervous System (6) · Demyelinating Autoimmune Diseases, CNS (6) · Demyelinating Diseases (6) · Immune System Diseases (6) · Nervous System Diseases (6) · Multiple Sclerosis (3)
Fingolimod Hydrochloride (2) · Glatiramer Acetate (2) · Interferon beta-1a (2) · Adrenal Cortex Hormones (1) · Dimethyl Fumarate (1) · Interferon beta-1b (1) · Loperamide (1) · Prednisone (1) · Simethicone (1)
Teva Branded Pharmaceutical Products R&D, Inc. (2) · Biogen (1) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1) · Heinrich-Heine University, Duesseldorf (1) · Rocky Mountain MS Research Group, LLC (1)
Australia (1) · Germany (1) · Italy (1) · United States (1)
Bernd Kieseier, Prof. (1) · Helene Brooks (1) · Jean-Louis Stril, MD (1) · John F Foley, MD (1) · Renato Mantegazza, MD (1)
2017 (1)